Table 5 Correlation between gene expression and clinicopathological features in CH patients
From: Characterization of chronic HCV infection-induced apoptosis
Variable N = 34 (%) | Bak N = 16 (%) | Fas N = 19 (%) | FasL N = 16 (%) | Bcl-2 N = 20 (%) |
|---|---|---|---|---|
Age (mean ± SD) |  |  |  |  |
44 ± 9.8 |  |  |  |  |
≤ 47: 18 (53) | 8 (44) | 13 (72) # | 8 (44) | 9 (50) |
> 47: 16 (47) | 8 (50) | 6 (38) | 8 (50) | 11 (69) |
Gender | Â | Â | Â | Â |
M: 31 (91) | 13 (41) | 17 (55) | 15 (48) | 18 (58) |
F: 3 (8) | 3 (100) # | 2 (67) # | 1 (33) | 2 (66) |
Steatosis | Â | Â | Â | Â |
Absent: (10) | 3 (30) | 3 (30) | 2 (20) | 4 (40) |
Minimal: (14) | 7 (50) | 9 (64) | 4 (29) | 10 (71) |
Moderate: (7) | 4 (57) | 5 (71) | 7 (100) | 5 (71) |
Marked: (3) | 2 (67) | 2 (67) | 3 (100) | 1 (33) |
Necrosis | Â | Â | Â | Â |
Absent: (26) | 12 (46) | 13 (50) | 9 (35) | 16 (62) |
Minimal: (8) | 4 (50) | 6 (75) | 7 (88) # | 4 (50) |
Necro-inflammation | Â | Â | Â | Â |
Absent: (10) | 4 (40) | 5 (50) | 0 (0) | 3 (30) |
Minimal: (15) | 8 (53) | 9 (60) | 8 (53) | 11 (73) |
Moderate: (9) | 4 (44) | 5 (56) | 8 (89) | 6 (67) |
Cirrhosis | Â | Â | Â | Â |
Present:12 (35) | 6 (50) | 6 (50) | 6(50) | 9 (75) # |
Absent: 22 (65) | 10 (45%) | 13 (59) | 10(45) | 11 (50) |
Hepatitis grade | Â | Â | Â | Â |
I &II: (26) | 11 (42) | 12 (46) | 9 (35) | 15 (58) |
III&IV: (8) | 5 (63) | 7 (88) # | 7 (88) # | 5 (63) |
Hepatitis stage | Â | Â | Â | Â |
I &II: (25) | 12 (48) | 13 (52) | 8 (32) | 16 (64) |
III &IV: (9) | 4 (44) | 6 (67) | 8 (89) # | 4 (44) |